Lee Hee-Young, president of the Korean Association of Stemcell Therapy, claims that stem cell therapy is more advantageous in treating COVID-19 patients.  He said that research has shown the effects of autologous stem… read more

Pfizer recently announced the results obtained from one of its Phase III studies that evaluated the safety and immunogenicity of its 20-valent pneumococcal conjugate vaccine also known as 20vPnc. The 20 serotypes included… read more

TraceLink, a pharma supply chain solutions provider introduced a new package of fast solutions designed to digitalize the pharmaceutical supply chain. In response to the novel COVID-19 pandemic, TraceLink has prioritized its strategies… read more

MilliporeSigma shares that manufacturers are most unlikely to use conventional stainless steel systems when developing COVID-19 vaccines despite the expected high volume needed. More and more biopharma race to rapidly develop vaccines against… read more

British American Tobacco (BAT) will be using its tobacco-based technology in making a vaccine candidate targeting COVID-19. The candidate has been developed by its own subsidiary, Kentucky BioProcessing (KBP). BAT’s spokesperson said that… read more

Through all the stages of bioprocessing, all developers and manufacturers point to heighten as numerous steps as possible. For upstream processes, the result is noteworthy when efficiency picks up through the advancement of… read more

Cytiva (formerly known as GE Healthcare Life Sciences) will be developing a sample resin to support a COVID-19 vaccine candidate that is to be developed by the University of Queensland. A team from… read more

The COVID-19 widespread has the bioprocessing division fighting to keep staff safe while maintaining the supply chain for immunization advancement. Researchers and specialists around the world are racing to decrease the spread of… read more

MicrofluidX, a pharmaceutical technology provider has raised over $1.7 million to help develop its cell bioprocessing technology. This newly acquired fund will be used to develop a working prototype of its bioprocessing platform… read more

During the research & development bioprocess, an engineer needs to know as many helpful candidates as possible. When it comes to monoclonal counter acting agent (mAb)-based biotherapeutics, a bio processor needs to get… read more